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Abstract
Background: HIV/AIDS related stigma interferes with the provision of appropriate care and
support for people living with HIV/AIDS. Currently, programs to address the stigma approach it as
if it occurs in isolation, separate from the co-stigmas related to the various modes of disease
transmission including injection drug use (IDU) and commercial sex (CS). In order to develop
better programs to address HIV/AIDS related stigma, the inter-relationship (or 'layering') between
HIV/AIDS stigma and the co-stigmas needs to be better understood. This paper describes an
experimental study for disentangling the layering of HIV/AIDS related stigmas.
Methods: The study used a factorial survey design. 352 medical students from Guangzhou were
presented with four random vignettes each describing a hypothetical male. The vignettes were
identical except for the presence of a disease diagnosis (AIDS, leukaemia, or no disease) and a co-
characteristic (IDU, CS, commercial blood donation (CBD), blood transfusion or no co-
characteristic). After reading each vignette, participants completed a measure of social distance that
assessed the level of stigmatising attitudes.
Results: Bivariate and multivariable analyses revealed statistically significant levels of stigma
associated with AIDS, IDU, CS and CBD. The layering of stigma was explored using a recently
developed technique. Strong interactions between the stigmas of AIDS and the co-characteristics
were also found. AIDS was significantly less stigmatising than IDU or CS. Critically, the stigma of
AIDS in combination with either the stigmas of IDU or CS was significantly less than the stigma of
IDU alone or CS alone.
Conclusion: The findings pose several surprising challenges to conventional beliefs about HIV/
AIDS related stigma and stigma interventions that have focused exclusively on the disease stigma.
Contrary to the belief that having a co-stigma would add to the intensity of stigma attached to
people with HIV/AIDS, the findings indicate the presence of an illness might have a moderating
effect on the stigma of certain co-characteristics like IDU. The strong interdependence between
the stigmas of HIV/AIDS and the co-stigmas of IDU and CS suggest that reducing the co-stigmas
should be an integral part of HIV/AIDS stigma intervention within this context.
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HIV/AIDS has been described as "the most devastating
epidemic humanity has even known" [1]. Over 40 million
people globally are estimated to be living with HIV/AIDS,
with developing countries bearing a disproportionate bur-
den of new cases[2]. Recent projections indicate that
unless effective intervention strategies are implemented,
HIV/AIDS incident cases will escalate rapidly, particularly
in Eastern Europe and Asia [2]. Although treatment, care,
and support programs for people living with HIV/AIDS
(PLWHA) are recognised as central to the global manage-
ment of the epidemic [2-4], HIV/AIDS-related stigma
remains a recognised obstacle to the successful implemen-
tation of such programs [2,4,5]. While negative public
attitudes towards PLWHA presents a difficult social issue,
prejudicial attitudes by health care professionals can
directly affect access to care at the point of service delivery
[6,7]. In this regard, reducing HIV/AIDS stigma is an inte-
gral part of a comprehensive approach to the delivery of
appropriate treatment and care [8].
To reduce HIV/AIDS stigma, one must understand the
nature of the stigma, especially in the context of the low
success rates reported by existing stigma intervention
studies [9]. One reason for the lack of success of these
interventions may lie in the multidimensional nature of
HIV/AIDS stigma. Although HIV/AIDS stigma is treated as
if it is a singular entity, PLWHA are also stigmatised by vir-
tue of stigmatised behaviours associated with the routes of
transmission such as injecting drug use (IDU) and com-
mercial sex (CS) [10,11] – referred to here as co-stigmas.
A PLWHA seeking treatment in a health care centre who is
also an injection drug user may be stigmatised because of
the HIV/AIDS, the IDU, or a combination of the two.
These co-stigmas, however, are generally ignored in
stigma intervention programs, even though they will both
have implications for the delivery of services to PLWHA.
The presence of co-stigma has been referred to as 'double
stigma', 'triple stigma', or layers of stigmas [12-14], and a
number of approaches have been developed to study this
phenomenon [12,15-17]. One quantitative approach
measures levels of stigmatising attitudes towards people
with HIV/AIDS and/or related co-stigmatised attributes,
typically using a series of written descriptions (vignettes)
to elicit attitudes [18-22].
Study participants, including physicians, nurses, social
workers and psychologists, have been found to respond
significantly more harshly towards vignettes describing
PLWHA than towards vignettes describing a less value-
laden disease such as leukaemia [20,23,24]. Similarly,
vignettes describing people with co-stigmas such as IDU
or homosexuality result in significantly harsher responses
than vignettes describing people with control characteris-
tics such as being heterosexual or having received a blood
transfusion [17,22,25].
What remains unanswered in these earlier studies, how-
ever, is how the stigma of HIV/AIDS is layered with the
stigma of a co-characteristic such as IDU. Understanding
this is relationship is potentially critical for the develop-
ment and management of health campaigns and pro-
grams targeting stigma reduction, which have thus far
focussed on the stigma of HIV/AIDS in isolation from its
co-stigmas [9].
Until very recently, one of the impediments to the quanti-
tative analysis of the relationships between stigmas had
been the lack of an analytic framework. An approach to
the empirical analysis of HIV layering was identified, but
it provided no original data to support its use [26]. Essen-
tially, the paper showed how the total stigma of a person
with two (or more) stigmatised characteristics could be
partitioned. Details of the actual approach are described
in that paper. In brief, however, consider a two-by-two
table representing the level of stigma experienced by peo-
ple who are HIV positive versus HIV negative, and/or
injection drug users versus not injection drug users. Each
cell in the table represents the average level of stigma
experienced by those four possible combinations: people
who are neither injection drug users nor HIV positive,
people who are either injection drug users or HIV positive
(but not both), people who are both HIV positive and
injection drug users. For those individuals with only one
of the two possible stigmas it is possible to write of the
'unique' stigma associated with a characteristic in the
absence of the other characteristic – crudely, the cell
mean. The value of the cell representing people with the
combination of the characteristics represents a potentially
unique HIV stigma, a potentially unique injection drug
use stigma, and either an additional or a reduced stigma
in virtue of having both characteristics.
Following this analytic framework, Figure 1 illustrates
three models of the inter-relationships between stigmas in
an individual with two stigmatised characteristics, such as
HIV/AIDS and IDU.
Model 1 illustrates the stigma of HIV/AIDS and a co-
stigma assuming that they are strictly additive. In this case
each source of stigma may be addressed independently
and is effectively how HIV/AIDS stigma is currently
treated. Model 2 illustrates the stigma of HIV/AIDS and a
co-stigma assuming that the two sources of stigma com-
pletely overlap with one another. Removing the stigma of
either one would have no effect on the total level of
stigma. The final model portrays a compromise between
the two earlier models, and is hypothesised to be the most
likely portrayal of the actual relationship between the dis-Page 2 of 12
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that the overall stigma is composed of (i) a portion of
stigma uniquely associated with being HIV-positive; (ii) a
portion that is uniquely associated with the co-stigma,
and (iii) a portion that is the shared effect of the two stig-
mas. In this case an intervention addressing only one
source of stigma will only remove that relatively small
portion unique to that stigma (i.e. the white portion). To
address the total stigma of HIV/AIDS, one would need to
deal with both the stigma of HIV/AIDS and the co-stigma.
The aim of this study is three fold. It is the first empirical
test of the framework proposed by Chan and Reidpath
[26]; and describes a study design and analytic approach
that allows the disentangling of the inter-relationships (or
layering) between the disease stigma of HIV/AIDS and its
co-stigmas. It provides data from a setting from which lit-
tle data has previously been obtained (Southern China),
and yet has important implications for the delivery of care
and support to PLWHA and the development of appropri-
ate stigma interventions. Finally, methodological weak-
nesses of the framework can be assessed.
Medical students were the study population. The choice
was driven in part for reasons of convenience, but largely
because as future health care providers, their attitudes
towards PLWHA have important ramifications for a
health care system's capacity to cope with increasing
demand determined by the epidemic [16,17,22].
Methods
The study employed an adaptation of a factorial survey
design. Vignettes were presented to participants and atti-
tudinal evaluations about each vignette were recorded.
Participants
Three hundred and sixty second year medical students at
a university in Guangzhou were invited to participate.
Eight elected not to. The 352 participants were almost
evenly split between males and females (male = 170,
female = 169, 13 unidentified) had a mean age of 20 (age
range = 16–24, SD = 0.85).
Setting
The study was conducted in Guangzhou, Southern China,
a region identified as having one of the fastest growing
HIV/AIDS epidemics in the world [27]. Despite a rela-
tively low HIV/AIDS prevalence of 1933 cumulative cases,
the reported HIV/AIDS incidence in Guangzhou increased
by 212% in the 12 months to September 2004, from 262
to 511 cases [27].
Guangzhou is also a fertile location for this study because
of China's long history of stigmatisation of behaviours
associated with HIV/AIDS transmission including IDU
and prostitution. Currently, 73% of all new cases of infec-
tion are associated with IDU, while 20% were associated
with sexual transmission [27].
Materials
Vignettes
The surveys utilised 15 possible vignettes designed to cap-
ture the interplay between a disease (no disease, AIDS,
leukaemia) and a potentially stigmatised co-characteristic
(no co-characteristic, blood transfusion, commercial
blood donation, visited commercial sex workers, IDU).
Adapted from the work of Kelly et al., each vignette was
constructed in three parts. Part 1 was a general description
of the 'idealised son' that was constant across all 15
vignettes, and created to conform with China's traditional
hierarchical principles on the roles and duties occupied by
different subjects in relation to the family and the state
[28,29]:
Male 'A' was bright and had many talents. He was con-
sidered to be a dutiful son to his parents, and a kind,
selfless and responsible person by everyone who knew
him.
When presented on its own without further elaboration, it
served as the base condition against which all others could
be contrasted. In those vignettes in which Part 2 was
included it described 'A"s deteriorating health:
Over the past six months, he developed a range of
health problems including fatigue, physical decline
and recurrent infections. He learned from his doctor
that he was seriously ill, and his family and friends
were said to have difficulty adjusting to his life-threat-
ening illness.
Part 2 ended with a diagnosis of either AIDS or leukaemia:
Three models of layeringFigure 1
Three models of layering.
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Part 3 of the vignette, when it was included, gave addi-
tional information about one of the following co-charac-
teristics:
Two years ago, he received a blood transfusion as a
routine part of a surgical procedure.
OR
Over the past two years, he has sold his blood on a
number of occasions;
OR
For the past two years, he has occasionally visited com-
mercial sex workers.
OR
For the past two years, he has occasionally engaged in
injecting drug use for recreational purposes;
A vignette was created from each one of the possible 3 × 5
(i.e. disease by co-characteristic) combinations, giving 15
possible vignettes in total.
Independent variables and covariates
There were two independent variables. There was the dis-
ease factor with three levels (none, leukaemia, AIDS),
where 'none' represented the base condition of no disease
and, consistent with previous studies, leukaemia repre-
sented a control disease. There was a second factor of co-
characteristics with five levels (none, blood transfusion,
blood donation, commercial sex, IDU), where 'none' rep-
resented the base condition of no co-characteristic, and
blood transfusion represented the control co-characteris-
tic. Given the sample size, there is a restriction on the
number of co-stigmatised factors that could be sensibly
explored in one study. Whilst homosexuality is a common
co-stigmatised factor included in previous studies, in the
current study, the co-stigmatised factors were selected on
the basis of their significance in terms of HIV transmission
in the local epidemic.
HIV/AIDS knowledge was treated as a covariate because
previous studies have shown that misconceptions regard-
ing HIV transmission can lead to avoidance attitudes
because of fear of infection from casual contact [30-32].
HIV/AIDS knowledge was measured using an 11-item
scale of Yes/No questions designed to test participants'
knowledge about the transmission of HIV/AIDS. These
questions were adapted from a number of knowledge
scales [15,33]. A score of 0 indicated no correct responses;
and a score of 11 indicated all correct responses.
The other potential covariates included were age and gen-
der.
Dependent (outcome) variable
Stigma was operationalised in terms of social distance, a
widely used measure of the degree to which a person is
willing to share a proximate social space with another [34-
36]. The scale, adapted by Kelly and colleagues
[17,20,37], was composed of eight items measuring par-
ticipants' willingness to interact with the hypothetical per-
son 'A' [see Additional file 1]. An eight-point Likert-type
scale (1 = most willingly; 8 = most unwillingly) was used
to rate willingness to share a social space. Social distance
was calculated as the sum of the seven items (i.e., a possi-
ble score of 8–56). Given the arbitrary nature of the meas-
ure, it was rescaled to lie between 0 (low stigma) and 100
(high stigma) presenting each participants score as a per-
centage of the scale maximum (%SM).
Survey
The survey was divided into three sections. The first sec-
tion collected demographic details. The second section
presented a series of three random vignettes, each portray-
ing one of the 15 possible descriptions of the hypothetical
person. Following each vignette was the adapted social
distance scale. The final section was a measure of HIV/
AIDS knowledge.
The repeated measurement in this instance, however, was
only used as a device to increase the sample size, (to over-
come the relatively small number of students in the sec-
ond year of the medical course). There was an implicit
trade-off between increasing the number of judgments
made about the hypothetical person and the potential
redundancy associated with repeated measurement. In
order to prevent a set response to each version of the
hypothetical person, surveys were individually printed
and constructed so that each complete survey elicited
responses to three versions of the hypothetical person:
one with AIDS, one with leukaemia, and one with no dis-
ease. Furthermore, no co-characteristic occurred in any
survey more than once. It also meant that in any block of
360 surveys, the presentation was counter-balanced such
that no two participants would read descriptions of the
same three versions of the hypothetical persons. The 360
possible three-vignette combinations were shuffled using
a random number generator prior to distribution.
The adaptation and (back) translation of the vignettes
went through a series of iterations and the final survey was
field tested for readability and sense with 15 medical stu-
dents.Page 4 of 12
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In a single morning, at the conclusion of lectures, research
assistants were provided with an opportunity to address
concurrent classes of second year medical students, and
invite them to participate in a survey on student attitudes.
A plain language statement of the research was distributed
and it was explained both orally and in the plain language
statement that participation was voluntary and the
responses were entirely anonymous. Students who did
not wish to participate were invited to leave the lecture
theatre. However, mindful of the potential for coerced
participation through such a public form of non-partici-
pation, students were also given alternative forms of non-
participation. Specifically, they were informed that they
could remain and choose not to submit the survey form or
submit a blank form. Separate signed consent was not
sought, because it was regarded as culturally inappropri-
ate and would raise unnecessary concerns about anonym-
ity.
Research assistants distributed the survey forms serially
from a randomly ordered master pile. Students were given
15 minutes to complete the surveys, and encouraged not
to look at others' responses. The distribution of vignettes
across the 15 possible disease and co-characteristic combi-
nations about 'A' can be found in Additional file 2.
Data Analysis
All analyses were conducted using of Intercooled Stata
version 8.2. In the first instance the scale properties of the
social distance scale were examined, and then the bivari-
ate relationship between the independent factors (disease
characteristic and co-characteristic), the covariates, and
social distance. The effect of the order of the presentation
of a vignette on social distance was included as a possible
confounding variable. Although the presentation of
vignettes was randomised, participants would have been
unfamiliar with these particular descriptions, and it was
felt that repeated exposure to the task may itself influence
the judgements.
A multivariable model in which the effects of the inde-
pendent factors (and interaction effects) were estimated,
controlling only for those covariates that were shown to
have statistically significant effects on stigma in the bivar-
iate tests. Adjusted cell means (without the model con-
stant) were calculated and the effect of the layering of
stigma examined.
The multivariable modelling was, conceptually, a straight-
forward analysis of social distance as a function of (a) the
disease characteristic and (b) the co-characteristic. It was
slightly complicated by the repeated measurement of
social distance within participants – each of whom was
asked to respond to three separate vignettes. The cluster-
ing of judgements associated with the repeated measure-
ment of social distance within participants was handled
using a two-level, maximum likelihood, multilevel regres-
sion analysis. In the model, social distance associated
with judgements were represented at level one, and partic-
ipants were represented at level two [38,39].
Ethics
The study was approved by the Deakin University Human
Research Ethics Committee.
Results
Bivariate and multivariable analyses
The internal reliability of the social distance scale was con-
firmed using Cronbach's alpha (α =.91) [see Additional
file 3]
The social distance scale was linearly transformed to lie in
the interval 0–100 (0 representing minimum social dis-
tance, 100 representing maximum social distance). Social
distance scores occurred over the entire range of the scale,
with a mean social distance of 30.4.
Bivariate analyses were conducted to examine the rela-
tionship between social distance and each of the inde-
pendent variables and covariates separately, including the
order of presentation (Table 1). In virtue of the clustered
nature of the data, the bivariate analyses were performed
using a maximum likelihood, multilevel (variance com-
ponents) regression analysis (Table 1).
The analysis showed the order of presentation to have a
statistically significant effect on participants' judgments
about social distance. As a percentage of the scale maxi-
mum, vignette two was, on average, 4.8% higher on the
social distance than vignette one (p = .005), and vignette
three was 6% higher (p < .001). That is, social distance
increased significantly with the increasing order of presen-
tation. None of the covariates (age, sex or HIV/AIDS
knowledge) had a statistically significant effect on social
distance.
The results were very different for the independent factors,
Disease and Co-Characteristic. For the Disease factor, Leu-
kaemia was significantly less stigmatising than no disease,
resulting in an average reduction in social distance of 7%
(p < .001). In contrast, AIDS was significantly more stig-
matising than no disease resulting in an average increase
in social distance of 7% (p < .001). As anticipated, having
a blood transfusion did not significantly increase social
distance above the base category. Likewise, commercial
blood donation did not significantly increase social dis-
tance (p = .235). In contrast, having engaged in a commer-
cial sex transaction increased social distance by an average
of 19% of the scale maximum (p < .001), and havingPage 5 of 12
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25% (p < .001).
In the multivariable model of social distance the order of
presentation was controlled for. Participants' sex, age, and
knowledge of HIV/AIDS, however, were not included as
covariates in virtue of their small and statistically non-sig-
nificant association with social distance in the bivariate
models. The focus of the multivariable model was the fac-
tors of Disease and Co-characteristic and their interaction
effects. Table 2 shows the results of the maximum likeli-
hood, multilevel (variance component) regression analy-
sis, which takes account of the clustering effect of the
repeated measures within participants. The intra-class cor-
relation was .35 indicating that a substantial proportion
of the variation in social distance was attributable to
within participant effects.
In the multivariable analysis the two factors and the inter-
action were statistically significant. The number of tests
(i.e. 14) that were conducted raises some issues about
Type I errors in multiple comparisons. For reasons dis-
cussed by Cook and Farewell (1996), however, this was
not regarded as problematic. The core questions revolved
around Leukaemia, AIDS, IDU, CS, and their interactions.
Most of the effects appeared to fall clearly one way or
another. Even using as conservative a correction for mul-
tiple comparisons as the Bonferroni adjustment, the only
questionable result would be the interaction effect
between Leukaemia and CS – for which there was not, in
any case, a specific a priori hypothesis.
In keeping with the literature, however, the pattern of
results suggested that AIDS, IDU, CS, and to a lesser
degree CBD, were each highly stigmatising. They
increased the social distance score between 9% and 44%
of the scale maximum. In contrast, BT in isolation had no
statistically significant effect to the level of stigma, con-
firming its suitability as a control co-characteristic. The
pattern of interaction also showed a moderating effect, as
anticipated by Reidpath and Chan (2005). Specifically,
the stigma associated with the co-occurrence of two highly
stigmatised attributes was not simply a summation of the
stigma of each; rather, the stigma appeared to lie generally
between the stigma of one and the stigma of the sum.
In contrast to the bivariate analyses, leukaemia in isola-
tion did not have a statistically significant moderating
effect on levels of stigma, however, it had a statistically sig-
nificant moderating effect on the stigma of IDU, but pos-
sibly not on the stigma of CS. In addition, commercial
blood donation as a co-characteristic decreased the level
of stigma associated with AIDS.
Following the approach described by Reidpath and Chan
[26], the layering of the stigmas between disease and co-
characteristics was examined. Using the figures presented
in Table 3, cell means (%SM) were calculated as the sum
of the disease coefficient, co-characteristic coefficient, and
the interaction effect (see Table 3).
Very different arrangements of layering were observed
between AIDS and the various co-characteristics, each of
Table 1: Bivariate analysis of social distance, adjusting for the effect of repeated judgements within participants1
Variable n
P/J
Unstandardised Coefficient Standard Error p 95% CI
Order (base = First) 352/1044
Second 4.81 1.7 .005 1.47 – 8.15
Third 6.06 1.7 .000 2.73 – 9.39
Age 346/1026 0.00 1.05 .997 -2.06 – 2.06
Sex (base = Male) 339/1005
Female -.78 1.81 .666 -4.34–2.77
Knowledge 352/1044 -.25 .50 .615 -1.24 – 0.73
Disease (base = None) 352/1044
Leukaemia -6.99 1.63 .000 -10.18 – -3.80
AIDS 7.39 1.63 .000 4.20 – 10.58
Co-Characteristic (base = None) 352/1044
BT .07 1.96 .972 -3.78 – 3.92
CBD 2.34 1.96 .235 -1.52 – 6.19
CS 19.06 1.98 .000 15.17 – 22.94
IDU 25.13 1.96 .000 21.29 – 28.97
1The analysis examined the order of the vignette presentation (Order); participants' age, sex, and knowledge of HIV/AIDS, the disease in the 
vignette, and the presence of a co-characteristic: none, blood transfusion, commercial blood donation (CBD), commercial sex (CS), and injecting 
drug use (IDU). The sample size for each analysis is also shown: both the total number of participants (P) and the total number of social distance 
judgments (J).Page 6 of 12
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that the layering effects are based on estimates with often
wide confidence intervals and this limits the extent to
which one can interpret the results.
Layering results
AIDS and IDU
Figure 2a shows the arrangement of stigmatisation of the
person with (1) AIDS in the absence of a co-characteristic
(left hand bar), (2) IDU in the absence of a disease (right
hand bar) and (3) the combination of AIDS and IDU
(middle bar). The height of the bars represents the effect
of these diseases/co-characteristics on social distance.
AIDS has the lowest effect on social distance, IDU has the
greatest effect on social distance, and the combination of
the two factors (i.e. AIDS and IDU) sits between the two.
Chi-square test confirmed that the difference on stigma
levels between AIDS alone and the combination of the
two factors is statistically significant, χ2(1) = 14.02, p <
.001. The difference on stigma levels between IDU alone
and the combination of the two factors is statistically sig-
nificant (χ2(1) = 5.22, p = .022). This layering arrange-
ment is also consistent with leukaemia and IDU (see
Figure 2b), where the level of stigma of the combination
of IDU and leukaemia is less than half of the stigma
attached to IDU alone, χ2(1) = 50.61, p < .001.
Figure 2a shows the social distance score shown in the
middle bar as a composite of the social distance associated
with IDU alone, and the 'shared' social distance of IDU
and AIDS. The smaller portion of the total social distance
shown in the middle bar is uniquely associated with IDU
(33%). The greater portion of the social distance (67%) is
'shared' and associated with the interaction between IDU
and AIDS.
There is no stigma that is uniquely associated with AIDS.
It is by reference to Table 2 that one possible explanation
for this can be found. If there were no statistically signifi-
cant interaction effects between AIDS and IDU, then the
social distance associated with a person having both char-
acteristics would be simply additive (i.e. the AIDS coeffi-
cient, 24.32, plus the IDU coefficient, 43.84, equals 68).
However, there is a statistically significant negative inter-
action effect (the coefficient IDU/AIDS), indicating that
the social distance associated with AIDS and IDU must be
less than the sum of the two unique social distance scores.
Table 3: Model estimates (MLE) of social distance scores as a 
function of co-characteristics and disease conditions.
Disease Conditions
Co-Characteristics No Disease Leukaemia AIDS
None 0.00 2.48 24.32
BT 5.00 5.93 16.17
CBD 9.13 4.83 19.72
CS 30.66 22.78 29.85
IDU 43.84 20.75 36.52
Table 2: Multivariable analysis of social distance, adjusting for the effect of repeated judgements within participants and controlling for 
the order of vignette presentation
Variable Unstandardised Coefficient Standard Error p 95% CI
Order (base= First)
Second 4.91 1.30 .000 2.37–7.44
Third 5.73 1.29 .000 3.20–8.26
Disease (base = None)
Leukaemia (L) 2.48 3.26 .447 -3.91 – 8.86
AIDS 24.32 3.31 .000 17.83 – 30.81
Co-Characteristic (base = None)
BT 5.00 3.27 .126 -1.40 – 11.41
CBD 9.13 3.26 .005 2.74 – 15.51
CS 30.66 3.27 .000 24.34 – 37.06
IDU 43.84 3.25 .000 37.48 – 50.20
Interaction Effects
L × BT -1.55 4.72 .742 -10.81 – 7.71
L × BS -6.77 4.72 .151 -16.01 – 2.47
L × CS -10.35 4.77 .030 -19.69 – -1.01
L × IDU -25.57 4.73 .000 -34.84 – -16.30
AIDS × BT -13.17 4.73 .006 -22.44 – -3.89
AIDS × CBD -13.15 4.78 .004 -22.51 – -3.79
AIDS × CS -25.13 4.76 .000 -34.46 – -15.79
AIDS × IDU -31.64 4.73 .000 -40.91 – -22.38
ICC = .35Page 7 of 12
(page number not for citation purposes)
BMC Public Health 2007, 7:280 http://www.biomedcentral.com/1471-2458/7/280Because the negative effect of the interaction is greater
than the social distance associated with AIDS but less than
the social distance of IDU, any unique AIDS social dis-
tance disappears entirely, and appears as shared between
IDU and AIDS.
AIDS and CS
Figure 2c presents the arrangement of stigmatisation of
the person with (1) AIDS in the absence of a co-character-
istic (left hand bar), (2) CS in the absence of a disease
(right hand bar), and (3) the combination of AIDS and CS
(middle bar). The heights of the three bars suggest that
AIDS has the lowest effect on social distance while the
effect of CS and the combination of the two factors have
similar effects on social distance. Chi-square test confirms
that AIDS has a significantly lower effect on social dis-
tance than CS (χ2(1) = 3.93, p = .047), but the difference
in stigma levels is not statistically significant between
AIDS and the two factors combined (χ2(1) = 2.84, p =
.092). Similarly, there are no statistically significant differ-
ence in the effect on social distance between CS and the
two factors combined (χ2(1) = .06, p = .804). This is in
sharp contrast with the effects observed in the control dis-
ease where the stigma of CS is significantly higher than the
stigma of CS and leukaemia combined (χ2(1) = 5.59, p =
0.018).
Like the layering arrangement of IDU and AIDS, the mid-
dle bar in Figure 2c is mostly made up of the 'shared'
stigma of CS and AIDS and a small level of stigma that is
uniquely associated with CS (19%). No stigma that is
uniquely associated with AIDS is observed. The negative
interaction effect between CS and AIDS (see Table 2) may
again hold the key to an explanation that will be discussed
later.
AIDS and CBD
Figure 2d shows the arrangement of stigmatisation of the
person with (1) AIDS in the absence of a co-characteristic
(left hand bar), (2) CBD in the absence of a disease (right
hand bar) and (3) the combination of AIDS and CBD
(middle bar). In contrast to the previous arrangements,
The layering arrangements between the stigmas of diseases and co-characteristicsFigure 2
The layering arrangements between the stigmas of diseases and co-characteristics. A. The layering of AIDS and 
injecting drug use (IDU). B. The layering of leukaemia and injecting drug use (IDU). C. The layering of AIDS and commercial sex 
(CS). D. The layering of AIDS and commercial blood donation (CBD).
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has the lowest effect on social distance; the effect of the
combination of the two factors sits in the middle. This
arrangement is the complete reversal of that observed
between AIDS and IDU.
Unlike the layering arrangements already discussed, the
stigma associated with AIDS alone made up 54% of the
total stigma in the middle bar, while the 'shared' stigma of
the co-characteristic and AIDS makes up 46% of the
stigma. There is no stigma that is uniquely associated with
CBD. This layering is similar to that of AIDS and the con-
trolled co-characteristic of blood transfusion, where AIDS
makes up 69% of the stigma and Blood transfusion 31%.
Additional post-hoc analyses
Previous studies have commonly reported that the stigma
attached to people with AIDS and a co-characteristic is sig-
nificantly more stigmatising than the control disease with
the same co-characteristic. Additional chi-square analyses
confirmed that this is true for the current dataset. As such,
AIDS layered with all four co-characteristics were signifi-
cantly more stigmatising than leukaemia layered with the
same co-characteristics. The results by co-characteristics
are as follows: IDU (χ2(1) = 23.62, p < .001), CS (χ2(1) =
4.51, p = .033), CBD (χ2(1) = 20.78, p < .001), and BT
(χ2(1) = 9.91, p = .002). Chi-square results also shows
that AIDS with BT was significantly more stigmatising
than BT alone (χ2(1) = 7.58, p = .006).
Discussion
The observed inter-relationship between HIV/AIDS
stigma and the three co-stigmas was as hypothesised, and
conforms to the last of the three models proposed[26].
The stigma of HIV/AIDS and the three co-stigmas are nei-
ther strictly additive nor completely overlapping. Instead,
the layering arrangement showed a portion of stigma that
is a 'shared' effect of the disease stigma and the co-stigma
as well as independent effects.
An important finding is that people with AIDS are not the
ones who are most stigmatised. The person who is an
injecting drug user without an accompanying disease is
most stigmatised. A drug user with AIDS ranks second, fol-
lowed by CS with no disease, and then CS with AIDS. This
is a finding commonly missed by research with the tradi-
tional focus which attends to HIV/AIDS as the most criti-
cal source of stigma (e.g. [17,21,40]. The results highlight
the need to understand the stigma of HIV/AIDS in a wider
context than the disease itself.
The magnitude of the 'shared' effect relative to the inde-
pendent effects of a disease or co-characteristic suggests
the extent to which the meanings of the two stigmas over-
lap, or may be derived from one another. For a number of
reasons, one might suspect that the disease stigma of HIV/
AIDS is a derivative of the negative meanings attached to
IDU and CS, and not the other way around. One can see
for instance that in the AIDS/CS and AIDS/IDU interac-
tion that there is a complete absence of a 'unique' AIDS
stigma. The contribution of AIDS to the overall stigma is
entirely embedded within the interaction. This explana-
tion is consistent with the natural history of the epidemic
in China where it is still a predominately IDU epidemic
(particularly in places like Guangzhou) [27,41]; and the
stigmatisation of IDU and CS predates the stigmatisation
of HIV/AIDS [42-44]. It is highly likely that for most
injecting drug users infected with HIV, the drug habit pre-
ceded infection, not the other way around [40,45]. This
logically places CS and IDU first in the causal order, fol-
lowed by AIDS.
Another challenge to the orthodox understanding of HIV/
AIDS stigma is the statistically significant drop in the lev-
els of stigma between an injecting drug user with no dis-
ease and an injecting drug user with AIDS (see Figure 2a).
One could interpret the results as showing that having
AIDS actually reduces the overall social distance of an
injecting drug user. The analogous relationship between
IDU and the control disease (leukaemia) suggests that this
may be a general (perhaps sympathetic) reaction (Figure
2b). This merits further investigations as does the contrary
finding that the moderating effect of illness on stigma is
missing in the layering of AIDS and CS.
The results have important implications for the delivery of
health care in settings where the co-characteristics are
more stigmatising than AIDS, and the co-characteristics
are the strongest determinants of infection. In these set-
tings most PLWHA attending a health service will be pos-
itive in virtue of being a drug user or having engaged in
CS. If stigma is a barrier to treatment and care, it is likely
that reducing the stigma associated with AIDS alone is not
enough if in the minds of health carers the occurrence of
AIDS marks a person as having the even more stigmatised
co-characteristic of CS or IDU. Indeed, focussing on the
AIDS alone may backfire and reduce any sympathetic
reaction that occurs towards an HIV-positive drug user.
That AIDS in the absence of an 'innocent' explanation
such as CBD is more stigmatising is also important (see
Table 3). It suggests that an 'innocent' explanation for
being sero-positive pre-empts the possibility that a person
had acquired AIDS as a by-product of some other stigma-
tising behaviour. Conversely, having AIDS without any
details about the mode of transmission leaves people
speculating about the mode of transmission. A 'spill-over'
effect seems to occur from the un-stated but suspected
stigma of a negative co-characteristic; a further indication
that the stigma of co-characteristics such as IDU and CSPage 9 of 12
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interesting implications for whether a PLWHA would or
should reveal the source of infection.
Speculatively, the data also speak to the constructs of
'guilty' and 'innocent' victims of AIDS described in the lit-
erature [46-48]. If the dichotomy is absolute, the stigma
for 'innocent' PLWHA should not significantly exceed that
of (1) the 'innocent' leukaemia victim with the same co-
characteristic, or (2) the 'innocent' person with only the
co-characteristic. Yet, such differences were found in the
data, indicating that there may be a limit to the stigma
exemption for 'innocent' victims of AIDS. However, the
finding may be due to the study design itself. The disease
and co-characteristic factors presented in each version of
the vignette were not mutually exclusive. Therefore, par-
ticipants could not be certain that a HIV-positive person
who engaged in blood transfusion did not also engage in
other unspecified stigmatised behaviours. This, of course
approximates the ambiguity of real life circumstances
where information about transmission is often unavaila-
ble even to health care professionals. Instead of the
dichotomised construct of guilty versus innocent, one
interpretation of the overall findings is that there might be
a gradient in the levels of guilt attached to different cate-
gories of people with AIDS; with those who engage in IDU
being the most guilty and those who could prove their
'innocence' being the least guilty.
Limitations
The research method used in the current study provides a
promising way for understanding the complexity of HIV/
AIDS-related stigma in a health care setting. The results are
not, however without limitations. The vignettes describe a
person who was in all respects culturally perfect except for
the minor 'lapses' of drug use and the occasional visit to a
sex worker. This description is probably a typical of the
underlying population it tries to represent and the results
must therefore be considered in this light. The partici-
pants were also a cohort of medical students from only
one university, raising questions of generalisability. Both
issues are, however, in many ways secondary. Developing
and testing an analytic framework for understanding the
interrelationships between HIV/AIDS stigma and a
selected number of its co-stigmas was more important
and limited generalisability of the actual results are in this
case of less concern. Nonetheless, more testing is required
to examine the adaptability of the approach to other set-
tings. In other settings, of course, the dynamics of layering
may vary (see for example, [49,50]. The diversity of layer-
ing would only serve to highlight the complexity of issue
of stigma and the need for developing more context spe-
cific understandings of the issue.
Another limitation is the operational definition of
'stigma' in terms of social distance. Although social dis-
tance is perhaps one of the most empirically valid means
for measuring stigma, further studies should look at incor-
porating measures that tap into other aspects of stigma
when examining the issue of layering. The approach
described here could be adapted for use with other attitu-
dinal scales that measure other aspect of stigma.
The current study also restricted the co-characteristics that
were explored. Other factors that merit investigation
include the co-stigma of homosexuality, the gender of the
person portrayed in the vignette, and the stigma associ-
ated with sex workers as opposed to their clients. The
modelling of triple stigmas (e.g. IDU, CS and AIDS) could
also be a fruitful line of future inquiry. As with all attitu-
dinal studies, cautions should be made when inferring
behaviour from the findings.
A final and important issue is with the variability in the
data themselves, shown by the wide confidence intervals
associated with the parameter estimates. Under these cir-
cumstances, particular inferences about the nature of the
layering should be regarded as broadly speculative, and
indicative of potentially useful, future lines of inquiry.
Notwithstanding these limitations, the study presents a
potentially useful way of considering the layering of stig-
matised characteristics.
Conclusion
The findings of this study indicate that, far from being a
coherent singular entity, HIV/AIDS related stigma over-
laps with a number of co-stigmas associated with the
modes of disease transmission. Variations in the ways dif-
ferent co-stigmas overlapped with HIV/AIDS stigma were
examined, with each having different implications for
stigma interventions. The most important was the extent
to which the co-stigmas of IDU and CS were layered upon
the disease stigma of HIV/AIDS suggesting that the co-stig-
mas should be taken into account in the development and
implementation of HIV/AIDS stigma interventions.
Although more work is needed, the research methods
used in the current study provided a way that would hope-
fully contribute to a better means of analysing the nature
of stigma as it relates to different HIV/AIDS epidemics.
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